Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Genetic Testing Market - Market Growth Analysis and Forecast | Technavio

Technavio Research
Posted on: 06 Mar 18

Technavio has announced its newest market research report on the global genetic testing market for the period 2018-2022 that will provide the latest updates on this popular market.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180306006049/en/

Technavio has published a new market research report on the global genetic testing market 2018-2022 under their healthcare and life sciences library. (Graphic: Business Wire)

Technavio’s updated research report will provide an in-depth analysis of the global genetic testing market, encompassing the drivers, trends, and challenges expected to impact the market. It will provide clients with actionable insights on the market and assist them in expanding into untapped market segments.

The updated research report on the global genetic testing market is a vital part of Technavio’s in-vitro diagnostics portfolio. Technavio covers a wide range of market research reports in the field of in-vitro diagnostics, considering the competitive vendor landscape and the top vendors in the market. Some of the topics in this sector include proteomics, infectious disease diagnostic testing, tissue diagnostics, and lung cancer liquid biopsy.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Save more with Technavio. Buy2 reports and get the third for FREE: View all Technavio’s current offers

Genetic testing: market growth analysis

The demand for genetic testing is increasing due to the increase in genetic mutations in fetuses and newborns and rising prevalence of hereditary genetic disorders and infectious diseases. In the US, many infants are born with congenital heart disease. Infants are susceptible to developing congenital heart disease due to factors such as genetic conditions, the consumption of medications or alcohol during pregnancy, or viral infection.

In the previous report, a senior research analyst at Technavio stated, “The increasing prevalence of genetic disorders has been one of the primary growth factors for the genetic testing market. CHD may occur in infants in varying patterns such as autosomal dominant, autosomal recessive, X-linked dominant, and X-linked recessive. The increasing demand for companion diagnostics is expected to drive the global genetic testing market.”

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Topics covered in the previous report included the following:

Key sectors

  • Predictive and diagnostic testing
  • Prenatal, newborn, and pre-implantation testing
  • Pharmacogenomic testing
  • Forensic, relationship, and ancestry testing

Key regions

  • Americas
  • APAC
  • EMEA

Other features

  • Market drivers
  • Market challenges
  • Market trends
  • Competitive landscape
  • And more

With the previous analysis as its starting point, the updated report on genetic testing by Technavio will re-evaluate the market, focusing on the new developments in this field. It will also take into consideration the external factors and new competitors, which are expected to impact the market. The in-vitro diagnosticssector is one of the fastest-growing segments because of the increase in the instances of infectious diseases.

 
Technavio’s best deals of the month!

Celebrate Earth Day and clean energy with Technavio. Get 30% discount on all Energy reports. Offer valid from 12(th) March - 18(th) March.

OR

Get 20% off on all Media and Entertainment Services reports. Offer valid only till the 31(st) of March.

 

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180306006049/en/

Business Wire
www.businesswire.com

Last updated on: 06/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.